Literature DB >> 15525351

Microarray analysis of gene expression in the rat vestibular nucleus complex following unilateral vestibular deafferentation.

Arata Horii1, Chisako Masumura, Paul F Smith, Cynthia L Darlington, Tadashi Kitahara, Atsuhiko Uno, Kenji Mitani, Takeshi Kubo.   

Abstract

To investigate the molecular background of vestibular compensation, a model of lesion-induced plasticity, we used a microarray analysis to examine genes that show asymmetrical expression between the bilateral vestibular nucleus complexes (VNCs) 6 h following unilateral vestibular deafferentation (UVD). Asymmetrical gene expression was then validated by a real-time quantitative PCR. Among the 88 genes for which the ipsilateral (ipsi) : contralateral (contra) was > 1.35, the number of known genes was 33 (38%), and the number of expressed sequence tag (EST) sequences was 55 (62%). Among the 130 genes for which the contra : ipsi was > 1.35, the number of known genes was 55 (42%), and the number of EST sequences was 75 (58%). Changes in some of the genes were consistent with previous studies; however, we found several new genes which could be functionally related to the molecular basis of the electrophysiological asymmetry between the VNCs following UVD. Ipsi > contra genes included the GABA(A) receptor rho subunit, regulatory proteins of G protein signaling, calcium signaling related molecules such as the voltage-dependent calcium channel alpha2/delta subunit 1, calcineurin subunit Abeta and Ca(2+) pump. Contra > ipsi genes included the neuronal high affinity glutamate transporter, 5-hydroxytryptamine receptor 1D, mitogen-activated protein kinase 12 and ubiquitin carboxy-terminal hydrolase L1.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15525351     DOI: 10.1111/j.1471-4159.2004.02781.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  8 in total

Review 1.  Gene expression profiling of the inner ear.

Authors:  Thomas Schimmang; Mark Maconochie
Journal:  J Anat       Date:  2015-09-25       Impact factor: 2.610

2.  GABA(A) receptor subunit expression in the guinea pig vestibular nucleus complex during the development of vestibular compensation.

Authors:  Catherine M Gliddon; Cynthia L Darlington; Paul F Smith
Journal:  Exp Brain Res       Date:  2005-07-14       Impact factor: 1.972

3.  Intrinsic membrane properties of central vestibular neurons in rodents.

Authors:  Daniel Eugène; Erwin Idoux; Mathieu Beraneck; L E Moore; Pierre-Paul Vidal
Journal:  Exp Brain Res       Date:  2011-02-18       Impact factor: 1.972

4.  Changes in protein expression in the rat medial vestibular nuclei during vestibular compensation.

Authors:  Janet M Paterson; Duncan Short; Peter W Flatman; Jonathan R Seckl; Alastair Aitken; Mayank B Dutia
Journal:  J Physiol       Date:  2006-07-06       Impact factor: 5.182

5.  Expression of doublecortin, a neuronal migration protein, in unipolar brush cells of the vestibulocerebellum and dorsal cochlear nucleus of the adult rat.

Authors:  S Manohar; N A Paolone; M Bleichfeld; S H Hayes; R J Salvi; J S Baizer
Journal:  Neuroscience       Date:  2011-12-17       Impact factor: 3.590

6.  Amino acid transporter (VIAAT, VGLUT2) and chloride cotransporter (KCC1, KCC2 and NKCC1) expression in the vestibular nuclei of intact and labyrinthectomized rat.

Authors:  Lyndell Eleore; Mohamed Reza Ardehali; Isabelle Vassias; Pierre-Paul Vidal; Catherine de Waele
Journal:  Exp Brain Res       Date:  2007-06-28       Impact factor: 1.972

Review 7.  Vestibular compensation: the neuro-otologist's best friend.

Authors:  Michel Lacour; Christoph Helmchen; Pierre-Paul Vidal
Journal:  J Neurol       Date:  2016-04-15       Impact factor: 4.849

8.  Differential Gene Expression Profile in the Rat Caudal Vestibular Nucleus is Associated with Individual Differences in Motion Sickness Susceptibility.

Authors:  Jun-Qin Wang; Rui-Rui Qi; Wei Zhou; Yi-Fan Tang; Lei-Lei Pan; Yi-Ling Cai
Journal:  PLoS One       Date:  2015-04-24       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.